TY  - JOUR

T1  - Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial

JO  - Diabetologia

PY  - 2009/11/01

AU  - de Galan BE

AU  - Zoungas S

AU  - Chalmers J

AU  - Anderson C

AU  - Dufouil C

AU  - Pillai A

AU  - Cooper M

AU  - Grobbee DE

AU  - Hackett M

AU  - Hamet P

AU  - Heller SR et al

ED  - 

DO  - DOI: 10.1007/s00125-009-1484-7

PB  - Springer Science and Business Media LLC

VL  - 52

IS  - 11

SP  - 2328

EP  - 2336

Y2  - 2024/12/22

ER  -